5 Key Takeaways

• 1

  Researchers identified small RNA molecules called oncRNAs that can serve as a cancer type barcode detectable in blood.

• 2

  The study cataloged over 260,000 high-confidence oncRNAs across 32 tumor types, showing specific patterns linked to tissue origin.

• 3

  OncRNA presence-absence patterns function as digital signatures, distinguishing cancer types and subtypes effectively.

• 4

  A retrospective analysis of breast cancer patients indicated that changes in oncRNA levels correlate with treatment response and survival.

• 5

  An oncRNA-based assay could simplify post-treatment monitoring and improve early detection of persistent disease.